193 related articles for article (PubMed ID: 10973946)
1. Type 1 11beta -hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets.
Davani B; Khan A; Hult M; Mårtensson E; Okret S; Efendic S; Jörnvall H; Oppermann UC
J Biol Chem; 2000 Nov; 275(45):34841-4. PubMed ID: 10973946
[TBL] [Abstract][Full Text] [Related]
2. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
Swali A; Walker EA; Lavery GG; Tomlinson JW; Stewart PM
Diabetologia; 2008 Nov; 51(11):2003-11. PubMed ID: 18779947
[TBL] [Abstract][Full Text] [Related]
3. Regulation of 11beta-hydroxysteroid dehydrogenase type 1 and glucose-stimulated insulin secretion in pancreatic islets of Langerhans.
Ortsäter H; Alberts P; Warpman U; Engblom LO; Abrahmsén L; Bergsten P
Diabetes Metab Res Rev; 2005; 21(4):359-66. PubMed ID: 15586384
[TBL] [Abstract][Full Text] [Related]
4. 11beta-hydroxysteroid dehydrogenase is a predominant reductase in intact rat Leydig cells.
Leckie CM; Welberg LA; Seckl JR
J Endocrinol; 1998 Nov; 159(2):233-8. PubMed ID: 9795363
[TBL] [Abstract][Full Text] [Related]
5. 11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated.
Napolitano A; Voice MW; Edwards CR; Seckl JR; Chapman KE
J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):251-60. PubMed ID: 9618026
[TBL] [Abstract][Full Text] [Related]
6. Characterization of 11beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines.
Bland R; Worker CA; Noble BS; Eyre LJ; Bujalska IJ; Sheppard MC; Stewart PM; Hewison M
J Endocrinol; 1999 Jun; 161(3):455-64. PubMed ID: 10333548
[TBL] [Abstract][Full Text] [Related]
7. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues.
Stokes J; Noble J; Brett L; Phillips C; Seckl JR; O'Brien C; Andrew R
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1629-38. PubMed ID: 10845579
[TBL] [Abstract][Full Text] [Related]
8. Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone.
Cooper MS; Walker EA; Bland R; Fraser WD; Hewison M; Stewart PM
Bone; 2000 Sep; 27(3):375-81. PubMed ID: 10962348
[TBL] [Abstract][Full Text] [Related]
9. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.
Kotelevtsev Y; Holmes MC; Burchell A; Houston PM; Schmoll D; Jamieson P; Best R; Brown R; Edwards CR; Seckl JR; Mullins JJ
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14924-9. PubMed ID: 9405715
[TBL] [Abstract][Full Text] [Related]
10. Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11beta-hydroxysteroid dehydrogenase.
Schmid J; Ludwig B; Schally AV; Steffen A; Ziegler CG; Block NL; Koutmani Y; Brendel MD; Karalis KP; Simeonovic CJ; Licinio J; Ehrhart-Bornstein M; Bornstein SR
Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13722-7. PubMed ID: 21825133
[TBL] [Abstract][Full Text] [Related]
11. Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice.
Harris HJ; Kotelevtsev Y; Mullins JJ; Seckl JR; Holmes MC
Endocrinology; 2001 Jan; 142(1):114-20. PubMed ID: 11145573
[TBL] [Abstract][Full Text] [Related]
12. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1.
Jamieson PM; Nyirenda MJ; Walker BR; Chapman KE; Seckl JR
J Endocrinol; 1999 Jan; 160(1):103-9. PubMed ID: 9854182
[TBL] [Abstract][Full Text] [Related]
13. Decreased 11β-Hydroxysteroid Dehydrogenase 1 Level and Activity in Murine Pancreatic Islets Caused by Insulin-Like Growth Factor I Overexpression.
Chowdhury S; Grimm L; Gong YJ; Wang B; Li B; Srikant CB; Gao ZH; Liu JL
PLoS One; 2015; 10(8):e0136656. PubMed ID: 26305481
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic analysis of mice bearing targeted deletions of 11beta-hydroxysteroid dehydrogenases 1 and 2 genes.
Holmes MC; Kotelevtsev Y; Mullins JJ; Seckl JR
Mol Cell Endocrinol; 2001 Jan; 171(1-2):15-20. PubMed ID: 11165006
[TBL] [Abstract][Full Text] [Related]
15. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice.
Morton NM; Holmes MC; Fiévet C; Staels B; Tailleux A; Mullins JJ; Seckl JR
J Biol Chem; 2001 Nov; 276(44):41293-300. PubMed ID: 11546766
[TBL] [Abstract][Full Text] [Related]
16. Identification of a kinetically distinct activity of 11beta-hydroxysteroid dehydrogenase in rat Leydig cells.
Ge RS; Gao HB; Nacharaju VL; Gunsalus GL; Hardy MP
Endocrinology; 1997 Jun; 138(6):2435-42. PubMed ID: 9165033
[TBL] [Abstract][Full Text] [Related]
17. 11Beta-hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes.
Maser E
Cancer Res; 1998 Jul; 58(14):2996-3003. PubMed ID: 9679962
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity.
Berger J; Tanen M; Elbrecht A; Hermanowski-Vosatka A; Moller DE; Wright SD; Thieringer R
J Biol Chem; 2001 Apr; 276(16):12629-35. PubMed ID: 11278270
[TBL] [Abstract][Full Text] [Related]
19. 7α-hydroxylation of dehydroepiandrosterone does not interfere with the activation of glucocorticoids by 11β-hydroxysteroid dehydrogenase in E(t)C cerebellar neurons.
Gottfried-Blackmore A; Jellinck PH; Vecchiarelli HA; Masheeb Z; Kaufmann M; McEwen BS; Bulloch K
J Steroid Biochem Mol Biol; 2013 Nov; 138():290-7. PubMed ID: 23851218
[TBL] [Abstract][Full Text] [Related]
20. In vivo characterization of 11beta-hydroxysteroid dehydrogenase in rat hippocampus using glucocorticoid neuroendangerment as an endpoint.
Ajilore OA; Sapolsky RM
Neuroendocrinology; 1999 Feb; 69(2):138-44. PubMed ID: 9986927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]